The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma-Reference-Cited by-同舟云学术

The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma

Published:2018-07-17 Issue:3 Volume:7 Page:265-274
ISSN:1948-7894
Container-title:Journal of Radiation Oncology
language:en
Short-container-title:J Radiat Oncol

Author:

Chen T. W.,Wandrey N. E.,Ha C. S.,Eng Tony Y.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1007/s13566-018-0357-4/fulltext.html

Reference28 articles.

1. Ferlay J, Soerjomataram I, Ervik M et al (2013) Cervical Cancer. In: Ferlay J, Soerjomataram I, Ervik M et al (eds) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, Lyon, France

2. Huang Z, Mayr NA, Gao M, Lo SS, Wang JZ, Jia G, Yuh WTC (2012) Onset time of tumor repopulation for cervical cancer: first evidence from clinical data. Int J Radiat Oncol Biol Phys 84:478–484

3. Withers HR, Taylor JM, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

4. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161

5. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143